P2X3-mediated peripheral sensitization of neuropathic pain in resiniferatoxin-induced neuropathy

Experimental Neurology

Volumn 235, Issue 1, 2012, Pages 316-325

  Hsieh, Yu Lin ^a,b   Chiang, Hao ^a   Lue, June Horng ^a   Hsieh, Sung Tsang ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Activating transcription factor 3; Calcitonin gene related peptide; Mechanical allodynia; P2X3; Peripheral sensitization; Purinergic receptor; Resiniferatoxin; Small fiber neuropathy

Indexed keywords

5 [[(3 PHENOXYBENZYL)(1,2,3,4 TETRAHYDRO 1 NAPHTHYL)AMINO]CARBONYL]TRIMELLITIC ACID; ACTIVATING TRANSCRIPTION FACTOR 3; CALCITONIN GENE RELATED PEPTIDE; PERIPHERIN; PURINERGIC P2X3 RECEPTOR; RESINIFERATOXIN;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPOALGESIA; MALE; MOUSE; NEUROFILAMENT; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RESINIFERATOXIN INDUCED NEUROPATHY; SENSORY NEUROPATHY; SPINAL GANGLION;

ANIMALS; DITERPENES; GANGLIA, SPINAL; HYPERALGESIA; MALE; MICE; MICE, INBRED ICR; NEURALGIA; NEURONS; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; RECEPTORS, PURINERGIC P2X3; SKIN;

EID: 84859882029     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.02.013     Document Type: Article

References (37)

1. Attal N., Cruccu G., Baron R., Haanpaa M., Hansson P., Jensen T.S., Nurmikko T. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. 2010, 17:e1113-e1188.
2. Avelino A., Cruz F. Peptide immunoreactivity and ultrastructure of rat urinary bladder nerve fibers after topical desensitization by capsaicin or resiniferatoxin. Auton. Neurosci. 2000, 86:37-46.
3. Banerjee B., Medda B.K., Schmidt J., Zheng Y., Zhang Z., Shaker R., Sengupta J.N. Altered expression of P2X3 in vagal and spinal afferents following esophagitis in rats. Histochem. Cell Biol. 2009, 132:585-597.
4. Baron R. Neuropathic pain: a clinical perspective. Handb. Exp. Pharmacol. 2009, 3-30.
5. Baron R., Tolle T.R., Gockel U., Brosz M., Freynhagen R. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms. Pain 2009, 146:34-40.
6. Bouhassira D., Attal N., Willer J.C., Brasseur L. Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation. Pain 1999, 80:265-272.
7. Braz J.M., Basbaum A.I. Differential ATF3 expression in dorsal root ganglion neurons reveals the profile of primary afferents engaged by diverse noxious chemical stimuli. Pain 2010, 150:290-301.
8. Brown D.C., Iadarola M.J., Perkowski S.Z., Erin H., Shofer F., Laszlo K.J., Olah Z., Mannes A.J. Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model. Anesthesiology 2005, 103:1052-1059.
9. Burnstock G. Purinergic receptors and pain. Curr. Pharm. Des. 2009, 15:1717-1735.
10. Cavanaugh D.J., Lee H., Lo L., Shields S.D., Zylka M.J., Basbaum A.I., Anderson D.J. Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:9075-9080.
11. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 1994, 53:55-63.
12. Cheng H.T., Dauch J.R., Hayes J.M., Hong Y., Feldman E.L. Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes. J. Neuropathol. Exp. Neurol. 2009, 68:1229-1243.
13. Dussor G., Zylka M.J., Anderson D.J., McCleskey E.W. Cutaneous sensory neurons expressing the Mrgprd receptor sense extracellular ATP and are putative nociceptors. J. Neurophysiol. 2008, 99:1581-1589.
14. Finnerup N.B., Sindrup S.H., Jensen T.S. The evidence for pharmacological treatment of neuropathic pain. Pain 2010, 150:573-581.
15. Fukuoka T., Yamanaka H., Kobayashi K., Okubo M., Miyoshi K., Dai Y., Noguchi K. Re-evaluation of the phenotypic changes in L4 dorsal root ganglion neurons after L5 spinal nerve ligation. Pain 2012, 153:68-79.
16. Gibbons C.H., Wang N., Freeman R. Capsaicin induces degeneration of cutaneous autonomic nerve fibers. Ann. Neurol. 2010, 68:888-898.
17. Hai T., Hartman M.G. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 2001, 273:1-11.
18. Hsieh Y.L., Chiang H., Tseng T.J., Hsieh S.T. Enhancement of cutaneous nerve regeneration by 4-methylcatechol in resiniferatoxin-induced neuropathy. J. Neuropathol. Exp. Neurol. 2008, 67:93-104.
19. Iadarola M.J., Mannes A.J. The vanilloid agonist resiniferatoxin for interventional-based pain control. Curr. Top. Med. Chem. 2011, 11:2171-2179.
20. Kaan T.K., Yip P.K., Patel S., Davies M., Marchand F., Cockayne D.A., Nunn P.A., Dickenson A.H., Ford A.P., Zhong Y., Malcangio M., McMahon S.B. Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats. Brain 2010, 133:2549-2564.
21. Kalliomaki M., Kieseritzky J.V., Schmidt R., Hagglof B., Karlsten R., Sjogren N., Albrecht P., Gee L., Rice F., Wiig M., Schmelz M., Gordh T. Structural and functional differences between neuropathy with and without pain?. Exp. Neurol. 2011, 231:199-206.
22. Kissin I., Szallasi A. Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials. Curr. Top. Med. Chem. 2011, 11:2159-2170.
23. Lin Y.Y., Tseng T.J., Hsieh Y.L., Luo K.R., Lin W.M., Chiang H., Hsieh S.T. Depletion of peptidergic innervation in the gastric mucosa of streptozotocin-induced diabetic rats. Exp. Neurol. 2008, 213:388-396.
24. Neubert J.K., Karai L., Jun J.H., Kim H.S., Olah Z., Iadarola M.J. Peripherally induced resiniferatoxin analgesia. Pain 2003, 104:219-228.
25. Obrosova I.G. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 2009, 6:638-647.
26. O'Connor A.B., Dworkin R.H. Treatment of neuropathic pain: an overview of recent guidelines. Am. J. Med. 2009, 122:S22-S32.
27. Oliveira M.C., Pelegrini-da-Silva A., Tambeli C.H., Parada C.A. Peripheral mechanisms underlying the essential role of P2X3,2/3 receptors in the development of inflammatory hyperalgesia. Pain 2009, 141:127-134.
28. Pan H.L., Khan G.M., Alloway K.D., Chen S.R. Resiniferatoxin induces paradoxical changes in thermal and mechanical sensitivities in rats: mechanism of action. J. Neurosci. 2003, 23:2911-2919.
29. Polydefkis M., Hauer P., Sheth S., Sirdofsky M., Griffin J.W., McArthur J.C. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 2004, 127:1606-1615.
30. Rage M., Van Acker N., Facer P., Shenoy R., Knaapen M.W., Timmers M., Streffer J., Anand P., Meert T., Plaghki L. The time course of CO2 laser-evoked responses and of skin nerve fibre markers after topical capsaicin in human volunteers. Clin. Neurophysiol. 2010, 121:1256-1266.
31. Seijffers R., Mills C.D., Woolf C.J. ATF3 increases the intrinsic growth state of DRG neurons to enhance peripheral nerve regeneration. J. Neurosci. 2007, 27:7911-7920.
32. Tschachler E., Reinisch C.M., Mayer C., Paiha K., Lassmann H., Weninger W. Sheet preparations expose the dermal nerve plexus of human skin and render the dermal nerve end organ accessible to extensive analysis. J. Invest. Dermatol. 2004, 122:177-182.
33. Tsuchihara T., Ogata S., Nemoto K., Okabayashi T., Nakanishi K., Kato N., Morishita R., Kaneda Y., Uenoyama M., Suzuki S., Amako M., Kawai T., Arino H. Nonviral retrograde gene transfer of human hepatocyte growth factor improves neuropathic pain-related phenomena in rats. Mol. Ther. 2009, 17:42-50.
34. Wildgaard K., Ringsted T.K., Hansen H.J., Petersen R.H., Werner M.U., Kehlet H. Quantitative sensory testing of persistent pain after video-assisted thoracic surgery lobectomy. Br. J. Anaesth. 2012, 108:126-133.
35. Xu G.Y., Shenoy M., Winston J.H., Mittal S., Pasricha P.J. P2X receptor-mediated visceral hyperalgesia in a rat model of chronic visceral hypersensitivity. Gut 2008, 57:1230-1237.
36. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.
37. Zylka M.J., Rice F.L., Anderson D.J. Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to Mrgprd. Neuron 2005, 45:17-25.